The IRDAI, after consultation with the Advisory Committee, and with...
Category:
Indian News
Latest
Centre issues stern warning against surrogate ads seen as harming consumers
“We are committed to working collaboratively with all stakeholders...
‘Money mule’ bank accounts on the rise in India: Report
Mule accounts are owned by people who are duped by fraudsters into...
Govt asks Serum, Bharat Biotech to lower price of Covid vaccines: Report
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for private hospitals.
Both vaccines are available to the central government at a rate of Rs 150 per dose.
India’s new COVID-19 cases stay above 320,000, 2771 deaths, army called to help
“Please note that a huge fall in daily cases … is largely due to a heavy fall in testing. This should not be taken as an indication of falling cases, rather a matter of missing out on too many positive cases!” Rijo M John, a professor and health economist at the Indian Institute of Management in the southern state of Kerala, said in a post on Twitter.
Govt bars use of liquid oxygen for non-medical purposes amid acute shortage
He said it was considered necessary to restrict industrial usage of oxygen for ensuring availability of adequate and uninterrupted supply of medical oxygen across the country for management of COVID-19 patients and necessary order in this regard was issued on April 22 to restrict the use of industrial oxygen.
Bharat Biotech seeks DCGI nod to extend shelf life of Covaxin: Report
The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius.
Union Health Secretary writes to states for systematic implementation of vaccination Phase III
The document also mentions that it is necessary for all CVCs to declare vaccine type, stock and prices for vaccination services being offered from May 1 onwards.In order for the public to make informed choices, vaccine types and prices will be displayed in the ‘appointments’ section.
India records over 3.52 lakh new COVID-19 cases, 2812 deaths
The total count of positive cases now stands at 1,73,13,163, including 1,95,123 deaths and 1,43,04,382 recoveries. As many as 27,93,21,177 samples have been tested for COVID-19 up to April 25, the Indian Council of Medical Research (ICMR) informed. Of these 14,02,367 samples were tested on Sunday.
FPIs pull out Rs 7,622 from Indian markets so far in April
FPIs have been “net sellers in the equity markets for five weeks in a row now”, noted Himanshu Srivastava, associate director – manager research, Morningstar India.
Srivastava said the recent spate of net outflows could be largely attributed to the enormous surge in the COVID-19 pandemic in India, which has led several states to impose restrictions to bring the situation under control.
PMO says 551 oxygen generation plants to be set up through PM Cares Fund
These dedicated plants will be established in identified government hospitals in district headquarters in various states and union territories, and their procurement will be done through the Health and Family Welfare ministry.
The PM Cares Fund had earlier this year allocated Rs 201.58 crores for installation of additional 162 dedicated PSA medical oxygen generation plants inside public health facilities in the country, the PMO noted.
Italy imposes travel ban from India over COVID variant
Many countries including Hong Kong, US, UK, Kuwait, France, New Zealand and Canada , have banned flights from India, citing COVID-19 cases and the “double mutant” virus being found in the country.
Iran, Kuwait, Indonesia and UAE are the latest additions to this list of countries that have banned India from their citizens’ travel lists.
India’s urban affluent hit by new virus wave after dodging first
With the so-called consuming class ravaged by the new wave, India’s growth is at risk because private consumption accounts for about 60% of India’s economy. The central bank’s consumer confidence survey is showing increasing pessimism on jobs and policy makers have said they stand ready to support growth in what is now the world’s epicenter of the pandemic.